The rise of copyright’s blockbuster initially fueled a period of growth for pharma, but recent developments present a murky outlook for those considering a stake. Generic versions are eating into revenue, and https://anitapkkg590988.imblogs.net/91013853/sildenafil-and-pharma-a-risky-investment